CDDF Society Session at ESMO Congress:
How to Improve Equal Access to Innovative Oncology Drugs in Europe?
Madrid, 27 September 2014
- Oncology drug approval in the era of personalized medicine: Do we have to change paradigms?
- Patient participation in clinical research: Need for change?
- Addressing the differences in healthcare across Europe
- How can we get drugs to be priced based on how much benefit they provide?
Download the programme of the session here
To have access to the session presentations, please contact CDDF Headquarters at email@example.com